For the Inventor, By the Inventor

Enter assignee name

South San Francisco, CA, United States of America

Ideaya Biosciences, Inc.

USPTO Granted Patents = 13

EPO Patents = 4

Trademarks = 1

Forward Citations = 6

Loading Chart...

Loading Chart...

29 inventors (with patents filed for the assignee):

Muzaffar Alam (7 out of 8 patents)

Hilary Plake Beck (7 out of 7 patents)

Michael Patrick Dillon (7 out of 61 patents)

4. Marcos Gonzalez-Lopez (6 out of 6 patents)

5. James Clifford Sutton, Jr (6 out of 6 patents)

6. Leah Cleary (4 out of 5 patents)

7. Melissa Fleury (4 out of 5 patents)

8. John E Knox (4 out of 5 patents)

9. Zhonghua Pei (4 out of 32 patents)

10. Richard Steel (3 out of 4 patents)

11. Zachary E R Newby (3 out of 4 patents)

12. James A Sutton (2 out of 13 patents)

13. Paul A Barsanti (2 out of 2 patents)

14. Marcus Michael Fischer (2 out of 2 patents)

15. Claire L Neilan (2 out of 2 patents)

13 patents: Sort by Forward Citations

1. 12509454 - Thiadiazolyl derivatives (2025-12-30),

2. 12503467 - 2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors (2025-12-23),

3. 12398131 - Thiadiazolyl derivatives as DNA polymerase theta inhibitors and uses thereof (2025-08-26),

4. 12269820 - Piperazine substituted indazole compounds as inhibitors of PARG (2025-04-08),

5. 12258354 - AhR modulators (2025-03-25),

6. 12115163 - Combination therapy comprising a MAT2A inhibitor and a type II PRMT inhibitor (2024-10-15),

7. 11584755 - Dihydrothieno[3,2-b]pyridine compounds (2023-02-21),

8. 11548867 - Amido compounds as AhR modulators (2023-01-10),

9. 11530220 - Substituted imidazo[1,5-a]pyrazines and [1,2,4]triazolo[4,3-a]pyrazines for the modulation of AhR (2022-12-20),

10. 11407764 - AhR modulators (2022-08-09),

11. 11084798 - 2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors (2021-08-10),

12. 11046691 - 2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors (2021-06-29),

13. 10815250 - AhR modulators (2020-10-27),

Ideaya Biosciences is a biotechnology company focused on the discovery and development of oncology therapeutics. The company utilizes a precision medicine approach to target specific genetic alterations driving cancer growth. Ideaya has a strong pipeline of small molecule therapies and strategic partnerships with leading biopharmaceutical companies.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

13 Patents

#80 in South San Francisco, CA

#5,489 in California

#23,148 in US

#43,688 in the World

South San Francisco, CA, United States of America

Ideaya Biosciences, Inc.

Forward Citations = 6

29 inventors:

Muzaffar Alam (7 out of 8 patents)

Hilary Plake Beck (7 out of 7 patents)

Michael Patrick Dillon (7 out of 61 patents)

4. Marcos Gonzalez-Lopez (6 out of 6 patents)

5. James Clifford Sutton, Jr (6 out of 6 patents)

Please report any incorrect information to support@idiyas.com

Loading…